- Home
- BWFG vs ANNX Comparison
BWFG vs ANNX Comparison
Compare BWFG & ANNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWFG
- ANNX
- Stock Information
- Founded
- BWFG 2002
- ANNX 2011
- Country
- BWFG United States
- ANNX United States
- Employees
- BWFG N/A
- ANNX N/A
- Industry
- BWFG Major Banks
- ANNX Biotechnology: Pharmaceutical Preparations
- Sector
- BWFG Finance
- ANNX Health Care
- Exchange
- BWFG Nasdaq
- ANNX Nasdaq
- Market Cap
- BWFG 333.1M
- ANNX 334.1M
- IPO Year
- BWFG N/A
- ANNX 2020
- Fundamental
- Price
- BWFG $43.92
- ANNX $3.43
- Analyst Decision
- BWFG Buy
- ANNX Strong Buy
- Analyst Count
- BWFG 2
- ANNX 4
- Target Price
- BWFG $53.00
- ANNX $13.00
- AVG Volume (30 Days)
- BWFG 22.8K
- ANNX 1.7M
- Earning Date
- BWFG 10-23-2025
- ANNX 11-13-2025
- Dividend Yield
- BWFG 1.81%
- ANNX N/A
- EPS Growth
- BWFG 88.52
- ANNX N/A
- EPS
- BWFG 3.66
- ANNX N/A
- Revenue
- BWFG $94,282,000.00
- ANNX N/A
- Revenue This Year
- BWFG $66.56
- ANNX N/A
- Revenue Next Year
- BWFG $14.45
- ANNX N/A
- P/E Ratio
- BWFG $11.99
- ANNX N/A
- Revenue Growth
- BWFG 30.93
- ANNX N/A
- 52 Week Low
- BWFG $26.39
- ANNX $1.29
- 52 Week High
- BWFG $48.03
- ANNX $7.64
- Technical
- Relative Strength Index (RSI)
- BWFG 54.86
- ANNX 63.04
- Support Level
- BWFG $40.45
- ANNX $2.89
- Resistance Level
- BWFG $45.69
- ANNX $3.60
- Average True Range (ATR)
- BWFG 1.41
- ANNX 0.21
- MACD
- BWFG 0.16
- ANNX 0.01
- Stochastic Oscillator
- BWFG 46.00
- ANNX 76.87
About BWFG Bankwell Financial Group Inc.
Bankwell Financial Group Inc is a bank holding company, engaged in providing financial products and services. It offers products related to commercial lending, retail lending, depository services, and others. The bank's commercial lending products includes owner-occupied commercial real estate loans, commercial real estate investment loans, commercial loans to small and mid-sized businesses and real estate construction and development loans. The retail lending products include residential mortgage loans, home equity lines of credit, and consumer installment loans. Its depository products include checking, savings, money market, certificates of deposit, noninterest-bearing demand, and time deposits.
About ANNX Annexon Inc.
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.